Doxy-PEP Could Be Prevention Strategy for Some Patients

Post-exposure prophylaxis (PEP) of doxycycline is recommended by the Centers for Disease Control and Prevention (CDC) for prevention of chlamydia, syphilis, and gonorrhea infections for men who have sex with men (MSM) and transgender women who have had a bacterial sexually transmitted infection (STI) within the past year, according to a new paper on doxycycline-PEP. But it also is a strategy that may work well for cisgender women who have a similar risk profile.